ITGAM and inflammatory bowel disease: HFD decreases tolerogenic (CD11c+ CD103+ CD11b+) and increases pro-inflammatory (CD11c+ CD103− CD11b+) DCs subpopulations in the gut [133] pointing it as an important factor in IBD pathogenesis [133].